Capricor Therapeutics Inc


Capricor Therapeutics Inc (CAPR) Announces Q4 2017 Operating Results and Corporate Update

Capricor Therapeutics Inc (NASDAQ:CAPR) reported its fourth quarter and full year 2017 financial results. It also provided a corporate update.

Capricor Therapeutics Inc (CAPR) Investors Throw Bullish Parade After H.C. Wainwright Boosts Price Target

Analyst spotlights a compelling path forward for DMD program and looks to key catalysts in fourth quarter.

Rodman and Renshaw Sings the Praises of Capricor Therapeutics, Inc. (CAPR); Here’s Why

On Tuesday, Capricor Therapeutics, Inc. (NASDAQ:CAPR) was granted FDA Rare Pediatric Disease Designation for CAP-1002, the company’s treatment for Duchenne muscular dystrophy (DMD) and …

Tuesday’s Wall Street News: Netflix, Inc. (NFLX), Capricor Therapeutics Inc (CAPR), Moleculin Biotech Inc (MBRX)

Netflix, Inc. (NASDAQ:NFLX) shares are shooting up in Tuesday’s trading session following the release of very impressive earnings results for the second quarter.

Capricor Therapeutics Inc (CAPR) Shares Skyrocket – Here’s Why

It’s a very rewarding trading day for investors in Capricor Therapeutics Inc (NASDAQ:CAPR) with shares up nearly 130%, making the stock Wall Street’s …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts